Hangzhou Chengyuan Genomics Company, an R&D tools startup, will market a single cell RNA sequencing device in China for Boston's 1CellBiO. The device, 1CellBiO inDropTM, provides a high-quality whole transcriptome profile of the cell, according to 1CellBiO, which added that the device is both flexible and cost-effective. Chengyuan will provide single cell analysis research services while also marketing the device. Terms of the agreement were not disclosed.
